Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 4628

San Antonio, TX 78229


Study Summary:

A phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of XXXXXXXXX 550 mg TID in the treatment of subjects with Non-constipation Irritable Bowel Syndrome.


Qualified Participants Must:

• Be 18 years of age or older
• Have a clinical diagnosis of Irritable Bowel Syndrome
• Have symptoms which include: abdominal discomfort, bloating and diarrhea


Qualified Participants May Receive:

Study medication and study-related medical evaluations at no cost. Reimbursement for time and travel may be provided.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.